Notes Payable (Details Narrative) - USD ($)				9 Months Ended
	Jun. 26, 2013	Jul. 15, 2012	May. 01, 2011	Sep. 30, 2015	Sep. 30, 2014	Jun. 30, 2014
Debt Instrument [Line Items]
Warrant shares				2,306,032
Repayments of notes payable					$ 83,233
Convertible Debt [Member]
Debt Instrument [Line Items]
Gross proceeds from issuance of debt	$ 5,300,000
Warrant shares	764,960
Debt issuance costs	$ 286,349
Debt face amount	$ 6,502,158
Warrants exercisable period	5 years
Warrant exercise price	$ 12.155					$ 3.40
Percentage of closing price compare to exercise price	110.00%
Warrant call notice percentage of warrant exercise price				250.00%
Warrants exercise, call notice threshold trading days	10 days
Warrants exercise, consecutive trading days preceding call notice period	20 days
Warrants exercise, trading days after call date	14 days
Estimated fair value of warrants (in dollars per share)	$ 2.329
Warrant call commencement (trading days)	5 days
Warrant call, trigger conditions been in effect (trading days)	15 days
Warrants exercise, call notice before expiration (trading days)	30 days
Warrants exercise, call notice before warrant call (trading days)	15 days
Estimated fair value of anti-dilution warrants (in dollars per share)	$ 1.2002
Change in Fair Value of Conversion Feature Liability	$ 2,398,280
Drug Wholesaler Notes Payable [Member]
Debt Instrument [Line Items]
Debt face amount			$ 147,866
Periodic payment			$ 10,000
Final payment		$ 7,866
Interest rate		12.00%
Notes Payable To Related Party [Member]
Debt Instrument [Line Items]
Interest rate						10.00%
Repayments of notes payable					$ 97,122
Volume Weighted Average Price [Member] | Convertible Debt [Member]
Debt Instrument [Line Items]
Warrant exercise price				$ 8.50